2014, Number 2
<< Back Next >>
Med Sur 2014; 21 (2)
Fibrilación auricular como predictor de mortalidad en pacientes con infarto agudo del miocardio
Aguilar-Zapata D, González-Chon O, Bogard-Fuentes CA, Moreno-Castańeda L, Chávez-Tapia NC, García-López S
Language: Spanish
References: 15
Page: 55-61
PDF size: 146.62 Kb.
ABSTRACT
Background. Atrial fibrillation coexists with acute coronary syndromes.
Predictors of atrial fibrillation in the acute coronary syndrome
context are: advanced age, heart failure symptoms, and ventricular
systolic dysfunction. Atrial fibrillation in association with acute coronary
syndrome increases mortality secondary to cerebrovascular
disease and heart failure.
Aim. Describe the morbid-mortality incidence
in patients with atrial fibrillation and its relation with acute
coronary syndromes.
Material and methods. Case-control studies
conducted in the Coronary Unit of Médica Sur. Cases were
defined as patients who presented with atrial fibrillation at admission
or during their hospitalization. Primary outcome was mortality.
Continuous variables were analyzed with Student’s-t test and categorical
variables with χ
2 test. An univariate and multivariate logistic
regression analysis were done to identify risk factors for atrial fibrillation
and death.
Results. A total of 239 patients with acute coronary
syndrome were included, 22 patients (9.2%) had atrial fibrillation
(12 without ST elevation and 10 with ST elevation). Patients with
acute coronary syndrome and atrial fibrillation were older compared
with the group without atrial firbilation (68
vs. 60 years, p =
0.002). Patients with atrial fibrilation patients have diabetes more
frequently (59
vs. 31%, p = 0.016), and heart failure (59
vs. 35%, p
= 0.036). Risk factors for atrial fibrillation were: age older than 55
years (OR 10.5, CI 95% 1.38-79.62), diabetes (OR 3.14, CI 95%
1.28-7.7) and smoking (OR 2.66, CI 95% 0.959-7.497). Atrial fibrillation
is an independent risk factor for overall mortality (OR 8.36,
CI 95% 1.7-40.17).
Conclusions. Atrial fibrillation in patients with
acute coronary syndrome is an independent risk factor for death.
Age, diabetes and smoking are associated with the presence of
atrial fibrillation in this group of patients.
REFERENCES
Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2001; 8(4): 1266i-lxx.
Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30(9): 1038-45.
Camm J, Kirchhof P, Lip G, Schotten U, Savelieva I. Guidelines for the management of atrial Fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Eur Heart J 2010; 31: 2369-429.
Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
Orea Tejeda A, Castillo Martinez L, Férez Santander S, Ortega Sánchez A. Programa Nacional de Registro de Insuficiencia Cardiaca. Resultados de un estudio multicéntrico mexicano. Med Int Mex 2004; 20(4): 243-52.
Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30(9): 1038-45.
Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000; 101: 969-74.
Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92: 1150-54.
Lubitz S, Magnani J, Ellinor P, Benjamin E. Atrial Fibrillation and Death After Myocardial Infarction Risk Marker or Causal Mediator? Circulation 2011; 123: 2063-5.
Behar S, Tanne D, Zion M, Reicher-Reiss H, Kaplinsky E, Caspi A. Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Cardiol 1992; 70: 816-8.
Jabre P, Jouven X, MD, Adnet F, Thabut G, et al. Atrial Fibrillation and Death After Myocardial Infarction. A Community Study. Circulation 2011; 123: 2094-21.
Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OTIMAAL experience. Eur Heart J 2005; 26: 350-6.
Laurent G, Dentan G, Moreau D, Zeller M, Laurent Y, Vincent- Martin M. Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 2005; 98: 608-14.
Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000; 140: 878-85.
Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001; 86: 527-32.